| General Information of Drug Metabolite (DM) (ID: DM019141) |
| DM Name |
Tivantinib Metabolite M15,16
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
UDP-glucuronosyltransferase 1A9 (UGT1A9)
|
DME0042
|
| Unclear - Unclear |
Tivantinib
|
[1] |
|
UDP-glucuronosyltransferase 1A9 (UGT1A9)
|
DME0042
|
| Unclear - Unclear |
Tivantinib
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Tivantinib |
DR3448
|
Phase 3 |
Solid tumour/cancer |
|
|
| References |
| 1 |
Stereoselective hydroxylation by CYP2C19 and oxidation by ADH4 in the in vitro metabolism of tivantinib
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
